Search Tag: AOP Health
2023 13 Dec
At the end of November 2023, AOP Orphan Pharmaceuticals GmbH ( AOP Health ), an Austrian pharmaceutical company based in Vienna, received authorization from the Canadian Health Authority (Health Canada) for its ultra-short-acting, cardioselective β1-blocker Landiolol. The drug is used in intensive care to treat atrial fibrillation and atrial flutter...Read more
2023 12 Dec
The entire EU pharmaceutical legislation is currently being negotiated. Among the regulations to be redefined are those concerning rare diseases. Experts fear that the planned changes – in particular by shortening protection periods – will lower the incentive for companies to conduct research in the field of rare diseases. This would reduce the availability...Read more
2023 07 Dec
Presented at the American Society of Hematology (ASH) 65th annual meeting AOP Orphan Pharmaceuticals GmbH (AOP Health), Vienna, Austria, announced the results of an analysis assessing the impact of an individually optimized dosing regimen of ropeginterferon alfa-2b on treatment response in patients with low-risk polycythemia vera (PV) 1 These...Read more
2023 14 Nov
To ensure the availability of new therapies for rare diseases, a functioning cooperation between the public sector, academic research and research-based companies is crucial. With this in mind, Vienna's City Councilor for Health, Social Affairs and Sport, Peter Hacker, paid the Austrian pharmaceutical company AOP Orphan Pharmaceuticals GmbH ("AOP Health")...Read more
2023 08 Nov
The Vienna-based pharmaceutical company AOP Orphan Pharmaceuticals GmbH (AOP Health), which specializes in rare diseases and critical care medicine , is repositioning itself strategically. In order to offer patients and healthcare professionals state-of-the-art therapy concepts not only today, but also in the future, AOP Health is introducing new...Read more
2023 18 Oct
AOP Health is devoted to long-term commitment, high quality, and continuity. Its vision is to be the most trusted company for advanced and innovative therapies in cardiology and pulmonology, haemato-oncology, critical care, neurology and metabolic disorders and rare diseases. Join us for the AOP Health ESICM Congress 2023 Lunch Satellite Symposium:...Read more
2023 08 Sep
World Sepsis Day falls on September 13. Sepsis, which kills more people in Austria each year than heart attacks, is caused by an infection which spreads through the body and damages our organs. A lot of people in the general public still do not know very much about this issue. Sepsis is one of the most common causes of death around the world....Read more
2023 29 Aug
The Vienna native has a wealth of experience in pharma and will be building up the European pioneer’s area of Patient Advocacy in the field of rare diseases and intensive care. As of June 2023, Marion Rottenberg has taken over the role of International Patient Advocacy Lead at AOP Health. In this position, she is responsible for the strategic...Read more